On Health of Medicaid Patients. The program is projected to reduce diabetes-related mortality by 9 percent and microvascular disease events by 15 percent among those who completed the program.
Read More »Diabetes Hospitalization Rates Falling in US, CDC Says
The CDC study found that the rate of people with diabetes admitted to a hospital for a potentially preventable reason fell 35 percent between 1994 and 2002. And the rate of kidney failure in diabetes patients has fallen about 30 percent since 1996.
Read More »The Inhaled Insulin Exubera, Shows Effectiveness in Study
Exubera, an inhaled insulin powder, worked as well in a study of 226 patients as injectable insulin.
Read More »Chromium Significantly Reduced Weight Gain Associated with Anti-diabetic Medicat
Chromium picolinate reduced weight gain associated with anti-diabetes drugs and also improved blood sugar control and insulin sensitivity.
Read More »Nationwide Recall of Insulin Syringe 1-cc, 28-Gauge 1/2-Inch 100’s
FDA Recalls the AccuSure Insulin Syringes made by Qualitest Pharmaceuticals, Inc.
Read More »Jogging May Cause More Diabetes-Related Hypoglycemia Risk than Team Sports
Moderate-intensity exercise such as light continuous jogging or cycling poses a greater risk of hypoglycemia than intermittent high-intensity exercise representative of the activity patterns of team and field sports such as soccer or hockey.
Read More »Reducing Obesity Takes More Than 1 Approach
The combination of sibutramine therapy, basic counseling, and a low-calorie diet structured to include meal replacements forms an effective three-pronged approach to weight loss and maintenance.
Read More »Gastroesophageal Reflux Disease in Diabetics, an under Diagnosed Complication.
Heartburn is noted in 42% of patients with neuropathy versus 24% patients without neuropathy.
Read More »Leg Fat Deposits Predict Insulin Resistance in the Metabolic Syndrome Patients,
Peripheral fat, unlike central fat, may offer protection against insulin resistance and atherosclerotic risk in healthy populations.
Read More »The Cannabinoid Effects of Rimonabant interact with Gherlin to Alter Food Intake
AMPK is an important mediator of both ghrelin and the endocannabinoids, and that both classes of agents have peripheral as well as central effects, and that they may interact at the cellular level.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.